Operating Income (Loss) in USD of Medpace Holdings, Inc. from Q1 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Medpace Holdings, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2015 to Q3 2025.
  • Medpace Holdings, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was $142M, a 26.3% increase year-over-year.
  • Medpace Holdings, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $507M, a 24% increase year-over-year.
  • Medpace Holdings, Inc. annual Operating Income (Loss) for 2024 was $447M, a 32.7% increase from 2023.
  • Medpace Holdings, Inc. annual Operating Income (Loss) for 2023 was $337M, a 20.9% increase from 2022.
  • Medpace Holdings, Inc. annual Operating Income (Loss) for 2022 was $279M, a 40.3% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Medpace Holdings, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $507M $142M +$29.5M +26.3% 01 Jul 2025 30 Sep 2025 10-Q 23 Oct 2025
Q2 2025 $478M $126M +$21.2M +20.1% 01 Apr 2025 30 Jun 2025 10-Q 22 Jul 2025
Q1 2025 $456M $114M +$9.45M +9.08% 01 Jan 2025 31 Mar 2025 10-Q 22 Apr 2025
Q4 2024 $447M $125M +$38.1M +43.6% 01 Oct 2024 31 Dec 2024 10-K 11 Feb 2025
Q3 2024 $409M $112M +$27.4M +32.2% 01 Jul 2024 30 Sep 2024 10-Q 23 Oct 2025
Q2 2024 $381M $105M +$26.8M +34.1% 01 Apr 2024 30 Jun 2024 10-Q 22 Jul 2025
Q1 2024 $355M $104M +$17.9M +20.7% 01 Jan 2024 31 Mar 2024 10-Q 22 Apr 2025
Q4 2023 $337M $87.3M +$10.9M +14.2% 01 Oct 2023 31 Dec 2023 10-K 11 Feb 2025
Q3 2023 $326M $84.9M +$7.08M +9.1% 01 Jul 2023 30 Sep 2023 10-Q 22 Oct 2024
Q2 2023 $319M $78.4M +$18.2M +30.1% 01 Apr 2023 30 Jun 2023 10-Q 23 Jul 2024
Q1 2023 $301M $86.2M +$22M +34.3% 01 Jan 2023 31 Mar 2023 10-Q 23 Apr 2024
Q4 2022 $279M $76.4M +$21.6M +39.3% 01 Oct 2022 31 Dec 2022 10-K 11 Feb 2025
Q3 2022 $257M $77.8M +$24.1M +44.9% 01 Jul 2022 30 Sep 2022 10-Q 24 Oct 2023
Q2 2022 $233M $60.2M +$17.8M +41.9% 01 Apr 2022 30 Jun 2022 10-Q 25 Jul 2023
Q1 2022 $215M $64.2M +$16.6M +34.9% 01 Jan 2022 31 Mar 2022 10-Q 25 Apr 2023
Q4 2021 $199M $54.9M -$133K -0.24% 01 Oct 2021 31 Dec 2021 10-K 13 Feb 2024
Q3 2021 $199M $53.7M +$7.29M +15.7% 01 Jul 2021 30 Sep 2021 10-Q 25 Oct 2022
Q2 2021 $191M $42.4M +$12.3M +40.9% 01 Apr 2021 30 Jun 2021 10-Q 26 Jul 2022
Q1 2021 $179M $47.6M +$12.1M +34.1% 01 Jan 2021 31 Mar 2021 10-Q 26 Apr 2022
Q4 2020 $167M $55M +$18.9M +52.2% 01 Oct 2020 31 Dec 2020 10-K 14 Feb 2023
Q3 2020 $148M $46.4M +$16.4M +54.8% 01 Jul 2020 30 Sep 2020 10-Q 26 Oct 2021
Q2 2020 $132M $30.1M -$5.13M -14.6% 01 Apr 2020 30 Jun 2020 10-Q 27 Jul 2021
Q1 2020 $137M $35.5M +$9.61M +37.1% 01 Jan 2020 31 Mar 2020 10-Q 27 Apr 2021
Q4 2019 $127M $36.1M +$5.45M +17.8% 01 Oct 2019 31 Dec 2019 10-K 25 Feb 2020
Q3 2019 $122M $30M +$3.07M +11.4% 01 Jul 2019 30 Sep 2019 10-Q 27 Oct 2020
Q2 2019 $119M $35.3M +$11.9M +51% 01 Apr 2019 30 Jun 2019 10-Q 28 Jul 2020
Q1 2019 $107M $25.9M +$5.78M +28.7% 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020
Q4 2018 $101M $30.7M +$15.2M +98.7% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2020
Q3 2018 $85.8M $26.9M +$9.72M +56.5% 01 Jul 2018 30 Sep 2018 10-K 25 Feb 2020
Q2 2018 $76.1M $23.3M +$7.07M +43.4% 01 Apr 2018 30 Jun 2018 10-K 25 Feb 2020
Q1 2018 $69M $20.1M +$4.18M +26.2% 01 Jan 2018 31 Mar 2018 10-K 25 Feb 2020
Q4 2017 $64.9M $15.4M +$2.55M +19.8% 01 Oct 2017 31 Dec 2017 10-K 26 Feb 2019
Q3 2017 $62.3M $17.2M +$4.58M +36.3% 01 Jul 2017 30 Sep 2017 10-K 26 Feb 2019
Q2 2017 $57.7M $16.3M +$2.17M +15.3% 01 Apr 2017 30 Jun 2017 10-K 26 Feb 2019
Q1 2017 $55.6M $15.9M +$3.08M +23.9% 01 Jan 2017 31 Mar 2017 10-K 26 Feb 2019
Q4 2016 $52.5M $12.9M +$13.8M 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2018
Q3 2016 $38.7M $12.6M +$5.42M +75.4% 01 Jul 2016 30 Sep 2016 10-K 27 Feb 2018
Q2 2016 $33.3M $14.1M +$6.25M +79.4% 01 Apr 2016 30 Jun 2016 10-K 27 Feb 2018
Q1 2016 $27M $12.9M +$6.48M +101% 01 Jan 2016 31 Mar 2016 10-K 27 Feb 2018
Q4 2015 $20.6M -$889K 01 Oct 2015 31 Dec 2015 10-K 28 Feb 2017
Q3 2015 $7.2M 01 Jul 2015 30 Sep 2015 10-K 28 Feb 2017
Q2 2015 $7.87M 01 Apr 2015 30 Jun 2015 10-K 28 Feb 2017
Q1 2015 $6.39M 01 Jan 2015 31 Mar 2015 10-K 28 Feb 2017

Medpace Holdings, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $447M +$110M +32.7% 01 Jan 2024 31 Dec 2024 10-K 11 Feb 2025
2023 $337M +$58.1M +20.9% 01 Jan 2023 31 Dec 2023 10-K 11 Feb 2025
2022 $279M +$80.1M +40.3% 01 Jan 2022 31 Dec 2022 10-K 11 Feb 2025
2021 $199M +$31.6M +18.9% 01 Jan 2021 31 Dec 2021 10-K 13 Feb 2024
2020 $167M +$39.8M +31.3% 01 Jan 2020 31 Dec 2020 10-K 14 Feb 2023
2019 $127M +$26.2M +25.9% 01 Jan 2019 31 Dec 2019 10-K 15 Feb 2022
2018 $101M +$36.2M +55.8% 01 Jan 2018 31 Dec 2018 10-K 16 Feb 2021
2017 $64.9M +$12.4M +23.6% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020
2016 $52.5M +$31.9M +155% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019
2015 $20.6M 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.